Global News

Alzheimer's Drug Discovery Foundation, OnDeckBiotech partner

Friday, June 27, 2014 11:12 AM

The Alzheimer's Drug Discovery Foundation (ADDF) and OnDeckBiotech, a Boston-based software company providing software tools for biotech, pharma and R&D service vendors, are partnering to provide a new platform technology for ADDF ACCESS, an open-access database that provides a network of CROs, drug development consultants and educational resources focused for diseases of the central nervous system (CNS).

More... »

WIRB Copernicus Group

Corgenix, VHFC receive $2.9M NIH grant to develop Ebola rapid diagnostic test kit

Friday, June 27, 2014 11:10 AM

Corgenix Medical, a worldwide developer and marketer of diagnostic test kits, has been awarded a three-year, $2.9 million NIH grant to advance the development of an Ebola rapid diagnostic test kit. Collaborating with Corgenix on the program will be members of the Viral Hemorrhagic Fever Consortium (VHFC), a collaboration of academic and industry members headed by Tulane University and partially funded by the NIH.

More... »

CRF Health eCOA webinar series

Merz to acquire medical device company Ulthera

Friday, June 27, 2014 11:09 AM

Specialty healthcare company Merz will acquire Ulthera, a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its ultrasound platform technology. The merger is valued at up to $600 million in upfront cash and milestone payments.

More... »

HedgePath Pharmaceuticals adds three new board members

Thursday, June 26, 2014 03:36 PM

HedgePath Pharmaceuticals, a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, has announced that Stefan J. Cross, Dr. R. Dana Ono and W. Mark Watson, CPA, have been appointed to HedgePath's board of directors.

More... »

FDA approves Sivextro to treat skin infections

Thursday, June 26, 2014 03:02 PM

The FDA has approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.

More... »

Battelle, BIO find bioscience industry has strong growth prospects

Thursday, June 26, 2014 02:18 PM

A study by Battelle and BIO analyzing the U.S. bioscience industry growth over the last 11 years—through recession and early economic recovery—reveals positive trends. The industry demonstrated a strong record of growth from 2001 to 2012, has navigated the deep economic recession better than most industries and is once again growing.

More... »

Study finds increased consideration given to sex and gender in research applications

Thursday, June 26, 2014 02:15 PM

More researchers submitting applications to the Canadian Institutes of Health Research (CIHR) are including sex and gender considerations in their proposals, according to a study published in the journal PLOS ONE. The study was co-authored by Dr. Joy Johnson, scientific director of the CIHR Institute of Gender and Health (IGH).

More... »

Debiopharm, Nobelex Biotech collaborate

Thursday, June 26, 2014 02:14 PM

Debiopharm Group, a Switzerland-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, and Nobelex Biotech, a Canadian company focusing on the discovery and early development of novel antimicrobial drugs, are collaborating on two discovery programs to develop antibiotics targeting Neisseria gonorrhoeae and enteric species utilizing a novel mechanism of action.

More... »

BioOutsource to open a Massachusetts lab facility in 2015

Thursday, June 26, 2014 02:13 PM

BioOutsource, a global provider of biologics contract testing and biosimilar characterization for the biopharmaceutical industry, plans to open a new North American testing facility in 2015. The last year has been an exceptional growth year for the company: global demand for outsourced testing services, coupled with BioOutsource’s continued investment in R&D and the opening of a BioSimilar Center of Excellence in Glasgow in February, has created the need to establish a new testing facility.

More... »

Applikon Biotechnology, SecureCell collaborate

Thursday, June 26, 2014 02:09 PM

Applikon Biotechnology and SecureCell have signed an agreement for the worldwide marketing and sales of Advanced Process Information Management Software developed by SecureCell. The software allows the user to monitor and control bioprocesses and offers an extensive toolbox for analyzing process data cross platforms. Process information is generated based on data from different brands of bioreactors and a wide range of different cultivation volumes.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs